Maternal plasma phospholipid polyunsaturated fatty acids in early pregnancy and thyroid function throughout pregnancy: a longitudinal study
The American Journal of Clinical Nutrition · 2024
DOI: 10.1016/j.ajcnut.2024.02.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Clinical Nutrition, 2024. Verfasst von Ling-Jun Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Global Centre for Asian Women's Health, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of O&G, Yong Loo Lin…. Hauptthemen laut MEDLINE: Phospholipids, Diabetes, Gestational. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
BACKGROUND: Evidence has indicated that polyunsaturated fatty acids (PUFAs)-enriched diet could reduce inflammation because of thyroid autoimmunity in vivo, and therefore, enhance thyroid function. OBJECTIVES: We investigated whether early pregnancy plasma phospholipid PUFAs could benefit maternal thyroid function across pregnancy, which is critical to fetal brain development and growth in pregnancy. METHODS: Within the National Institute of Child Health and Human Development Fetal Growth Studies-Singleton Cohort, we collected plasma samples longitudinally from 214 subjects [107 with gestational diabetes mellitus (GDM) matched with 107 controls] with a singleton pregnancy. We measured 11 PUFAs at early pregnancy (10-14 wk) and 5 thyroid biomarkers at 10-14, 15-26, 23-31, and 33-39 wk, including free thyroxine (fT4), free triiodothyronine (fT3), thyroid-stimulating hormone, antithyroid peroxidase, and antithyroglobulin. Associations of PUFAs with thyroid function biomarkers and relative risk (RR) of gestational hypothyroidism (GHT) during pregnancy were assessed using generalized linear mixed models and modified Poisson regression, respectively. RESULTS: After sample weighting because of subjects with GDM over-representing in the analytic sample with biomarkers, eicosapentaenoic acid (EPA) at early pregnancy was associated with a reduction of 0.24 pmol/L (95% confidence intervals: -0.31, -0.16) in fT3 across gestation per standard deviation (SD) increment, whereas docosahexaenoic acid (DHA) at early pregnancy was associated with an increment of 0.04 ng/dL (0.02, 0.05) in fT4 across gestation per SD increment. Furthermore, EPA and docosatetraenoic acid (DTA) were associated with lower risks of persistent GHT (EPA-RR: 0.13; 0.06, 0.28; DTA-RR: 0.24; 0.13, 0.44) per SD increment. All significant associations remained robust in sensitivity analysis and multiple testing. CONCLUSIONS: Certain plasma phospholipid PUFAs were associated with optimal levels of thyroid biomarkers and even lower risk of GHT throughout pregnancy, which might be potentially targeted for maternal thyroid regulation in early pregnancy. CLINICAL TRIAL REGISTRY: This trial was registered at https://beta. CLINICALTRIALS: gov/study/NCT00912132?distance=50&term=NCT00912132&rank=1 as NCT00912132.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Global Centre for Asian Women's Health, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of O&G, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; NUS…
- Division of Biostatistics, School of Medicine, Washington University in St. Louis, St. Louis, MO, United States.
- Department of Clinical and Preventive Nutrition Sciences, School of Health Professions, Rutgers Global Health Institute, Rutgers University, NJ, United States.
- Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
- Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, United States.
- Glotech Inc., Bethesda, MD, United States.
Förderung
- NHLBI NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Li, L. J., Lu, R., Rawal, S., Birukov, A., Weir, N. L., Tsai, M. Y., Wu, J., Chen, Z., & Zhang, C. (2024). Maternal plasma phospholipid polyunsaturated fatty acids in early pregnancy and thyroid function throughout pregnancy: a longitudinal study. The American Journal of Clinical Nutrition. https://doi.org/10.1016/j.ajcnut.2024.02.016
Vancouver
Li LJ, Lu R, Rawal S, Birukov A, Weir NL, Tsai MY, et al. Maternal plasma phospholipid polyunsaturated fatty acids in early pregnancy and thyroid function throughout pregnancy: a longitudinal study. The American Journal of Clinical Nutrition. 2024. doi:10.1016/j.ajcnut.2024.02.016
BibTeX
@article{Li2024,
author = {Li, Ling-Jun and Lu, Ruijin and Rawal, Shristi and Birukov, Anna and Weir, Natalie L and Tsai, Michael Y and Wu, Jing and Chen, Zhen and Zhang, Cuilin},
title = {Maternal plasma phospholipid polyunsaturated fatty acids in early pregnancy and thyroid function throughout pregnancy: a longitudinal study},
journal = {The American Journal of Clinical Nutrition},
year = {2024},
doi = {10.1016/j.ajcnut.2024.02.016}
}
EUVIMED